The Valley Desk

NCT00799825 · Interventional trial

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US

Overall registry status Completed

Phase 3

Conditions Infections, Papillomavirus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov